Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1974 1
1976 2
1977 1
1978 1
1979 3
1981 6
1982 1
1983 2
1985 2
1986 1
1987 2
1988 3
1989 7
1991 3
1992 1
1993 1
1994 1
1995 1
1996 2
1998 3
1999 1
2000 2
2001 1
2002 1
2004 1
2005 3
2006 2
2007 2
2008 1
2009 1
2015 1
2016 1
2017 2
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Corrigendum to "A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report" [Eur J of Canc (2017) 206-225].
Gnekow AK, Walker DA, Kandels D, Picton S, Giorgio Perilongo, Grill J, Stokland T, Sandstrom PE, Warmuth-Metz M, Pietsch T, Giangaspero F, Schmidt R, Faldum A, Kilmartin D, De Paoli A, De Salvo GL; Low Grade Glioma Consortium and the participating centers. Gnekow AK, et al. Eur J Cancer. 2018 Feb;90:156-157. doi: 10.1016/j.ejca.2017.11.017. Epub 2017 Dec 14. Eur J Cancer. 2018. PMID: 29248309 Free PMC article. No abstract available.
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report.
Gnekow AK, Walker DA, Kandels D, Picton S, Giorgio Perilongo, Grill J, Stokland T, Sandstrom PE, Warmuth-Metz M, Pietsch T, Giangaspero F, Schmidt R, Faldum A, Kilmartin D, De Paoli A, De Salvo GL; of the Low Grade Glioma Consortium and the participating centers. Gnekow AK, et al. Eur J Cancer. 2017 Aug;81:206-225. doi: 10.1016/j.ejca.2017.04.019. Epub 2017 Jun 22. Eur J Cancer. 2017. PMID: 28649001 Free PMC article. Clinical Trial.
Long-term risk of second malignant neoplasm after a cancer in childhood.
de Vathaire F, Schweisguth O, Rodary C, François P, Sarrazin D, Oberlin O, Hill C, Raquin MA, Dutreix A, Flamant R. de Vathaire F, et al. Among authors: rodary c. Br J Cancer. 1989 Mar;59(3):448-52. doi: 10.1038/bjc.1989.92. Br J Cancer. 1989. PMID: 2930714 Free PMC article.
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32).
Brédart A, Bottomley A, Blazeby JM, Conroy T, Coens C, D'Haese S, Chie WC, Hammerlid E, Arraras JI, Efficace F, Rodary C, Schraub S, Costantini M, Costantini A, Joly F, Sezer O, Razavi D, Mehlitz M, Bielska-Lasota M, Aaronson NK; European Organisation for Research and Treatment of Cancer Quality of Life Group and Quality of Life Unit. Brédart A, et al. Among authors: rodary c. Eur J Cancer. 2005 Sep;41(14):2120-31. doi: 10.1016/j.ejca.2005.04.041. Eur J Cancer. 2005. PMID: 16182120
Differential item functioning (DIF) in the EORTC QLQ-C30: a comparison of baseline, on-treatment and off-treatment data.
Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA; EORTC Quality of Life Group and the Quality of Life Cross-Cultural Meta-Analysis Group. Scott NW, et al. Qual Life Res. 2009 Apr;18(3):381-8. doi: 10.1007/s11136-009-9453-7. Epub 2009 Feb 27. Qual Life Res. 2009. PMID: 19247808
62 results